- Service Name
MaxWell Biosystems
- Industry
Biotechnology, Research, Neuroscience, Electrophysiology
- Main Value Proposition
MaxWell Biosystems provides innovative electrophysiology solutions that enable researchers to gain deeper insights into cellular behavior and drug interactions.
- Description
MaxWell Biosystems offers advanced high-resolution microelectrode array (MEA) technology designed to enhance neuroscience research and facilitate preclinical drug discovery. Their products enable detailed functional imaging and analysis of cellular activity.
- Key Features
CMOS-based multiwell high-density microelectrode array platform; Label-free detection of sub-cellular and network activity; Selective electrical stimulation capabilities; Comprehensive data analysis tools
- Use Cases
The service is most valuable in scenarios such as drug discovery, safety pharmacology, toxicology studies, and research involving iPSC-derived neurons and neuronal networks.
- Competitive advantages
High-resolution imaging capabilities that allow for detailed analysis of cellular activity; Long-term monitoring of single-cell dynamics and network interactions; User-friendly software for large-scale data handling and visualization
- Strengths
MaxWell Biosystems excels in providing high-quality, reliable MEA technology that supports a wide range of applications in neuroscience and drug discovery.
- Positioning
MaxWell Biosystems positions itself as a leader in high-resolution electrophysiology solutions, catering to the needs of advanced neuroscience research.
- Audience
The primary target users include neuroscientists, pharmacologists, and researchers in academia and industry focused on drug development and cellular research.
- CTA
Request a Quote
- Tags
Electrophysiology
Neuroscience
Drug Discovery
Microelectrode Arrays
- Tagline
High-throughput, high-resolution functional imaging
- Tone of Voice
Professional, informative, innovative
- Differentiation
The service stands out in the market due to its integration of advanced CMOS technology within the MEA systems, allowing for compact and powerful data collection directly from the cells.
- Brand Positioning
The brand is identified as innovative and cutting-edge, emphasizing its commitment to enhancing research capabilities in neuroscience and drug discovery.
- Founded
2016-01-01
- Founders
Urs Frey